Inherited susceptibility to bleomycin-induced chromatid breaks in cultured peripheral blood lymphocytes

Journal of the National Cancer Institute

Volumn 91, Issue 13, 1999, Pages 1125-1130

  Cloos, Jacqueline ^a   Nieuwenhuis, Eline J C ^a   Boomsma, Dorret I ^b   Kuik, Dirk J ^b   Van Der Sterre, Marianne L T ^a   Arwert, Fré ^b   Snow, Gordon B ^a   Braakhuis, Boudewijn J M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CARCINOGEN;

ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENIC ACTIVITY; CHROMATID ABERRATION; DNA DAMAGE; FAMILY HISTORY; GENETIC ANALYSIS; GENETIC PREDISPOSITION; HEAD AND NECK CANCER; HUMAN; LYMPHOCYTE CULTURE; MUTAGENICITY; NORMAL HUMAN; PEDIGREE ANALYSIS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; TWIN ZYGOSITY;

EID: 0033532841     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.13.1125     Document Type: Article

References (32)

1. Maier H, Dietz A, Gewelke U, Heller WD, Weidauer H. Tobacco and alcohol and the risk of head and neck cancer. Clin Investig 1992;70:320-7.
2. Baron AE, Franceschi S, Barra S, Talamini R, La Vecchia C. A comparison of the joint effects of alcohol and smoking on the risk of cancer across sites in the upper aerodigestive tract. Cancer Epidemiol Biomarkers 1993;2: 519-23.
3. Perera FP. Environment and cancer: who are susceptible? Science 1997; 278:1068-73.
4. Hecht SS. Environmental tobacco smoke and lung cancer: the emerging role of carcinogen biomarkers and molecular epidemiology [editorial]. J Natl Cancer Inst 1994;86:1369-70.
5. Spivack SD, Fasco MJ, Walker VE, Kaminsky LS. The molecular epidemiology of lung cancer. Crit Rev Toxicol 1997;27:319-65
6. Vineis P, Bartsch H, Caporaso N, Harrington AM, Kadlubar FF, Landi MT, et al. Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens. Nature 1994;369:154-6.
7. Kato S, Bowman ED, Harrington AM, Blomeke B, Shields PG. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo [published erratum appears in J Natl Cancer Inst 1995;87:861-2]. J Natl Cancer Inst 1995;87:902-7.
8. Hsu TC, Johnston DA, Cherry LM, Ramkissoon D, Schantz SP, Jessup JM, et al. Sensitivity to genotoxic effects of bleomycin in humans: possible relationship to environmental carcinogenesis. Int J Cancer 1989;43:403-9.
9. Scott D, Spreadborough A, Levine E, Roberts SA. Genetic predisposition in breast cancer [letter]. Lancet 1994;344:1444.
10. Cloos J, Braakhuis BJ, Steen I, Copper MP, de Vries N, Nauta JJ, et al. Increased mutagen sensitivity in head- and-neck squamous-cell carcinoma patients, particularly those with multiple primary tumors. Int J Cancer 1994;6:816-9.
11. Cloos J, Spitz MR, Schantz SP, Hsu TC, Zhang Z, Tobi H, et al. Genetic susceptibility to head and neck squamous cell carcinoma. J Natl Cancer Inst 1996;88:530-5.
12. Hermanek P, Sobin LH, editors. TNM classification of malignant tumours. 4th ed. Berlin (Germany): Springer-Verlag; 1987, p. 13-26.
13. Boomsma DI. Twin registers in Europe: an overview. Twin Res 1998;1: 34-51.
14. Becker A, Busjahn A, Faulhaber HD, Bahring S, Robertson J, Schuster H, et al. Twin zygosity. Automated determination with microsatellites. J Reprod Med 1997;42:260-6.
15. Hsu TC. Genetic predisposition to cancer with special reference to mutagen sensitivity. In Vitro Cell Devel Biol 1987;23:591-603.
16. Lange K, Weeks D, Boehnke M. Programs for Pedigree Analysis: MENDEL, FISHER, and dGENE. Genet Epidemiol 1988;5:471-2.
17. Lange K, Westlake J, Spence MA. Extensions to pedigree analysis. III. Variance components by the scoring method. Ann Hum Genet 1976;39: 485-91.
18. Cloos J, Bongers V, Lubsen H, Tobi H, Braakhuis BJ, Snow GB. Lack of effect of daily N-acetylcysteine supplementation on mutagen sensitivity. Cancer Epidemiol Biomarkers 1996;5:941-4.
19. Spitz MR, McPherson RS, Jiang H, Hsu TC, Trizna Z, Lee JJ, et al. Correlates of mutagen sensitivity in patients with upper aerodigestive tract cancer. Cancer Epidemiol Biomarkers 1997;6:687-92.
20. Taylor AM, Byrd PJ, McConville CM, Thacker S. Genetic and cellular features of ataxia telangiectasia. Int J Radiat Biol 1994;65:65-70.
21. Joenje H, Mathew C, Gluckman E. Fanconi anaemia research: current status and prospects. Eur J Cancer 1995;31A:268-72.
22. Knight RD, Parshad R, Price FM, Tarone RE, Sanford KK. X-ray-induced chromatid damage in relation to DNA repair and cancer incidence in family members. Int J Cancer 1993;5:589-93.
23. Bondy ML, Spitz MR, Halabi S, Fueger JJ, Schantz SP, Sample D, et al. Association between family history of cancer and mutagen sensitivity in upper aerodigestive tract cancer patients. Cancer Epidemiol Biomarkers 1993;2:103-6.
24. Austin MJ, Collins JM, Corey LA, Nance WE, Neale MC, Schieken RM, et al. Aphidicolin-inducible common fragile-site expression: results from a population survey of twins. Am J Hum Genet 1992;50:76-83.
25. Swift M, Morrell D, Massey RB, Chase CL. Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 1991;325:1831-6.
26. Schantz SP, Spitz MR, Hsu TC. Mutagen sensitivity in patients with head and neck cancers: a biologic marker for risk of multiple primary malignancies. J Natl Cancer Inst 1990;82:1773-5.
27. Spitz MR, Hoque A, Trizna Z, Schantz SP, Amos CI, King TM, et al. Mutagen sensitivity as a risk factor for second malignant tumors following malignancies of the aerodigestive tract. J Natl Cancer Inst 1994;86:1681-4.
28. Sellers TA, Chen PL, Potter JD, Bailey-Wilson JE, Rothschild H, Elston RC. Segregation analysis of smoking-associated malignancies: evidence for Mendelian inheritance. Am J Med Genet 1994;50:308-14.
29. Copper MP, Jovanovic A, Nauta JJ, Braakhuis BJ, de Vries N, van der Waal I, et al. Role of genetic factors in the etiology of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1995; 121:157-60.
30. Brugarolas J, Jacks T. Double indemnity: p53, BRCA and cancer. p53 mutation partially rescues developmental arrest in Brcal and Brca2 null mice, suggesting a role for familial breast cancer genes in DNA damage repair [news]. Nat Med 1997;3:721-2.
31. Ponder BA. Inherited predisposition to cancer. Trends Genet 1990;6: 213-8.
32. Cinciripini PM, Hecht SS, Henningfield JE, Manley MW, Kramer BS. Tobacco addiction: implications for treatment and cancer prevention. J Natl Cancer Inst 1997;89:1852-67.